Mesa Laboratories, Inc. (MLAB)

Revenue by Segment

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Calibration Solutions	51.75M	47.76M	44.81M	46.87M	46.93M
Calibration Solutions Growth	8.35%	6.60%	-4.41%	-0.12%	-9.26%
Clinical Genomics	47.08M	52.59M	62.30M	32.84M	-
Clinical Genomics Growth	-10.47%	-15.59%	89.70%	-	-
Biopharmaceutical Development	48.73M	40.71M	47.37M	45.58M	33.89M
Biopharmaceutical Development Growth	19.69%	-14.05%	3.92%	34.48%	144.69%
Sterilization and Disinfection Control	93.42M	75.12M	64.61M	59.04M	53.12M
Sterilization and Disinfection Control Growth	24.35%	16.27%	9.43%	11.15%	6.97%
Total	240.98M	216.19M	219.08M	184.34M	133.94M
Total Growth	11.47%	-1.32%	18.85%	37.63%	13.81%

Revenue by Geography

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
United States	116.62M	106.40M	117.28M	99.07M	71.39M
United States Growth	9.61%	-9.28%	18.38%	38.78%	7.60%
China	25.31M	24.93M	25.80M	16.52M	6.61M
China Growth	1.52%	-3.35%	56.18%	149.82%	-
Other	99.05M	84.86M	76.00M	68.75M	55.94M
Other Growth	16.72%	11.65%	10.55%	22.90%	-
Total	240.98M	216.19M	219.08M	184.34M	133.94M
Total Growth	11.47%	-1.32%	18.85%	37.63%	13.81%

Source: S&P Global Market Intelligence.